"AI is a powerful tool for catching potential quality issues but it’s only as good as the people using it," said director ...

A California-based company says it has created the world's first early-stage human egg cells from stem cells using lab-grown ...

This week, Ford Motor Company said that it has actually rehired hundreds of veteran human engineers over the past several years after AI failed to match their abilities, and it so ...

For the first time ever, scientists are attempting to reverse cellular aging in a living patient. The target: incurable ...

Scientists have taken a small but significant step toward testing the idea of reverse aging in humans. Researchers have ...

Katie has a PhD in maths, specializing in the intersection of dynamical systems and number theory. She reports on topics from maths and history to society and animals. Katie has a PhD in maths, ...

First human gets experimental gene shot to rewind ageing cells in the eye Life Biosciences has dosed its first patient with ER-100, a treatment that uses partial cellular reprogramming to target ...

Life Biosciences says it just dosed its first patient in an FDA-approved clinical trial to reverse age-related blindness.

Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now being tested in humans.

Plus: OpenAI has confidentially filed for a US IPO. This is today's edition of The Download, our weekday newsletter that provides a daily dose of what's going on in the world of technology. The ...

For Beijing-based METiS TechBio CEO Lai Tsai-ta, ageing is comparable to bugs building up in a complex software system – it happens once errors begin to accumulate in the genetic code of human cells, ...

With a drug candidate in hand sooner than expected, NewLimit plans to push into a phase 1 fatty liver disease trial next year. (iStock / Getty Images Plus) Anti-aging startup NewLimit is back with a ...